VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue2,488,6521,702,1771,032,336
Cost of Revenue275,119210,460124,512
Gross Profit2,213,5331,491,717907,824
Operating Expenses
Research Development1,324,6251,047,690995,922
Selling General and Administrative496,079432,829376,575
Non Recurring269,5861,2622,206
Others---
Total Operating Expenses---
Operating Income or Loss123,2439,936-466,879
Income from Continuing Operations
Total Other Income/Expenses Net-81,3824,130-6,715
Earnings Before Interest and Taxes41,86114,066-473,594
Interest Expense57,55081,43284,206
Income Before Tax-15,689-67,366-557,800
Income Tax Expense-107,32416,66530,381
Minority Interest13,727181,609153,661
Net Income From Continuing Ops263,484-112,052-556,334
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income263,484-112,052-556,334
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares263,484-112,052-556,334